PHASE I/II STUDY OF NC-6004, A NOVEL MICELLAR FORMULATION OF CISPLATIN, IN COMBINATION WITH GEMCITABINE IN PATIENTS WITH PANCREATIC CANCER IN ASIA - RESULTS OF PHASE I

被引：0
|
作者：
Su, W. [1 ]
Chen, L. [1 ]
Li, C. [2 ]
Chen, J. [3 ]
Lin, Y. [4 ]
Choo, S. [5 ]
Matsumura, Y. [6 ]
机构：
[1] Natl Cheng Kung Univ Hosp, Tainan 70428, Taiwan
[2] Taipei Vet Gen Hosp, Taipei, Taiwan
[3] Chang Gung Mem Hosp, Taipei 10591, Taiwan
[4] Natl Taiwan Univ Hosp, Taipei, Taiwan
[5] Natl Canc Ctr Singapore, Singapore, Singapore
[6] Natl Canc Ctr Hosp E, Kashiwa, Chiba, Japan
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：247 / 247
页数：1
相关论文
共 50 条
  • [41] Dual Src and EGFR inhibition in combination with gemcitabine in advanced pancreatic cancer: phase I results
    Cardin, Dana B.
    Goff, Laura W.
    Chan, Emily
    Whisenant, Jennifer G.
    Ayers, G. Dan
    Takebe, Naoko
    Arlinghaus, Lori R.
    Yankeelov, Thomas E.
    Berlin, Jordan
    Merchant, Nipun
    INVESTIGATIONAL NEW DRUGS, 2018, 36 (03) : 442 - 450
  • [42] Phase I/II Study of LDE225 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Cancer
    Pijnappel, Esther N.
    Wassenaar, Nienke P. M.
    Gurney-Champion, Oliver J.
    Klaassen, Remy
    van der Lee, Koen
    Pleunis-van Empel, Marjolein C. H.
    Richel, Dick J.
    Legdeur, Marie C.
    Nederveen, Aart J.
    van Laarhoven, Hanneke W. M.
    Wilmink, Johanna W.
    CANCERS, 2021, 13 (19)
  • [43] Phase I/II study of LDE225 in combination with gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer
    Pijnappel, E. N.
    Klaassen, R.
    van der Lee, K. S.
    Pleunis-van Empel, M.
    Richel, D.
    Legdeur, M.
    Nederveen, A.
    van Laarhoven, H. W. M.
    Wilmink, H. W.
    ANNALS OF ONCOLOGY, 2019, 30
  • [44] Phase I/II Study of Refametinib (BAY 86-9766) in Combination with Gemcitabine in Advanced Pancreatic cancer
    Jean-Luc Van Laethem
    Hanno Riess
    Jacek Jassem
    Michael Haas
    Uwe M. Martens
    Colin Weekes
    Marc Peeters
    Paul Ross
    John Bridgewater
    Bohuslav Melichar
    Stefano Cascinu
    Piotr Saramak
    Patrick Michl
    David Van Brummelen
    Alberto Zaniboni
    Wollf Schmiegel
    Svein Dueland
    Marius Giurescu
    Vittorio L. Garosi
    Katrin Roth
    Anke Schulz
    Henrik Seidel
    Prabhu Rajagopalan
    Michael Teufel
    Barrett H. Childs
    Targeted Oncology, 2017, 12 : 97 - 109
  • [45] Phase I/II Study of Refametinib (BAY 86-9766) in Combination with Gemcitabine in Advanced Pancreatic cancer
    Laethem, Jean-Luc Van
    Riess, Hanno
    Jassem, Jacek
    Haas, Michael
    Martens, Uwe M.
    Weekes, Colin
    Peeters, Marc
    Ross, Paul
    Bridgewater, John
    Melichar, Bohuslav
    Cascinu, Stefano
    Saramak, Piotr
    Michl, Patrick
    Van Brummelen, David
    Zaniboni, Alberto
    Schmiegel, Wollf
    Dueland, Svein
    Giurescu, Marius
    Garosi, Vittorio L.
    Roth, Katrin
    Schulz, Anke
    Seidel, Henrik
    Rajagopalan, Prabhu
    Teufel, Michael
    Childs, Barrett H.
    TARGETED ONCOLOGY, 2017, 12 (01) : 97 - 109
  • [46] Phase I trial of gemcitabine in patients with advanced pancreatic cancer
    Okada, S
    Ueno, H
    Okusaka, T
    Ikeda, M
    Furuse, J
    Maru, Y
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2001, 31 (01) : 7 - 12
  • [47] A phase I study of erlotinib, bevacizumab and gemcitabine in patients with advanced pancreatic cancer
    Gomez-Martin, C.
    Camara, J. C.
    Cortes, H.
    Jara, C.
    Gravalos, C.
    Rubio, B.
    Amador, M. L.
    Hidalgo, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [48] Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer
    Van Cutsem, Eric
    Hidalgo, Manuel
    Canon, Jean-Luc
    Macarulla, Teresa
    Bazin, Igor
    Poddubskaya, Elena
    Manojlovic, Nebojsa
    Radenkovic, Dejan
    Verslype, Chris
    Raymond, Eric
    Cubillo, Antonio
    Schueler, Armin
    Zhao, Charles
    Hammel, Pascal
    INTERNATIONAL JOURNAL OF CANCER, 2018, 143 (08) : 2053 - 2064
  • [49] A Phase I Study of Flavopiridol in Combination With Gemcitabine and Irinotecan in Patients With Metastatic Cancer
    Fekrazad, Houman M.
    Verschraegen, Claire F.
    Royce, Melanie
    Smith, Harriet O.
    Lee, Fa Chyi
    Rabinowitz, Ian
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (04): : 393 - 397
  • [50] A phase II study of combination chemotherapy with gemcitabine, 5-fluorouracil, and cisplatin for advanced pancreatic cancer
    Kim, S.
    Yuh, Y.
    Lee, H.
    EJC SUPPLEMENTS, 2009, 7 (02): : 388 - 388
12345